Back to Browse Journals » Clinical Pharmacology: Advances and Applications » Volume 2 » default

Clinical Pharmacology: Advances and Applications

Archive: Volume 2, 2010

Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine

Vincenzo Barrese, Francesco Miceli, Maria Virginia Soldovieri, et al

Clinical Pharmacology: Advances and Applications 2010, 2:225-236

Published Date: 7 December 2010

Editorial Foreword

Arthur E Frankel

Clinical Pharmacology: Advances and Applications 2010, 2:223-224

Published Date: 25 November 2010

Intrapleural therapy in management of complicated parapneumonic effusions and empyema

AlaEldin H Ahmed, Tariq E Yacoub

Clinical Pharmacology: Advances and Applications 2010, 2:213-221

Published Date: 22 November 2010

A comparative study of DNA damage in patients suffering from diabetes and thyroid dysfunction and complications

Nima V Thakkar, Sunita M Jain

Clinical Pharmacology: Advances and Applications 2010, 2:199-205

Published Date: 22 September 2010

In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compounds

Ulrike Olszewski, Thomas Tuxen Poulsen, Ernst Ulsperger, et al

Clinical Pharmacology: Advances and Applications 2010, 2:177-183

Published Date: 14 September 2010

Clinical efficacy of beta1 selective adrenergic blockers in the treatment of neurocardiogenic syncope – a meta-analysis

Srikanth Vallurupalli, Smita Das

Clinical Pharmacology: Advances and Applications 2010, 2:163-167

Published Date: 15 September 2010

The interaction between clopidogrel and proton pump inhibitors (PPI): is there any clinical relevance?

Rakesh K Sharma, Hanumanth K Reddy, Rohit K Sharma, et al

Clinical Pharmacology: Advances and Applications 2010, 2:155-162

Published Date: 6 September 2010

Testosterone replacement in male hypogonadism

Sanjay Kalra, Navneet Agrawal, Satish Kumar, et al

Clinical Pharmacology: Advances and Applications 2010, 2:149-153

Published Date: 10 September 2010

Rituximab in severe skin diseases: target, disease, and dose

Daniel D Bennett, Maro Ohanian, Christian T Cable

Clinical Pharmacology: Advances and Applications 2010, 2:135-141

Published Date: 7 July 2010

Managing insulin resistance: role of liraglutide

Sanjay Kalra, Bharti Kalra, Satish Kumar, et al

Clinical Pharmacology: Advances and Applications 2010, 2:131-134

Published Date: 24 June 2010

Clinical outcomes of antimicrobial lock solutions used in a treatment modality: a retrospective case series analysis

P Brandon Bookstaver, Katherine R Gerrald, Robert R Moran

Clinical Pharmacology: Advances and Applications 2010, 2:123-130

Published Date: 17 June 2010

Somatotropin in the treatment of growth hormone deficiency and Turner syndrome in pediatric patients: a review

Christina Southern Reh, Mitchell E Geffner

Clinical Pharmacology: Advances and Applications 2010, 2:111-122

Published Date: 1 June 2010

A common variant in the adiponectin gene on weight loss and body composition under sibutramine therapy in obesity

Tun-Jen Hsiao, Lawrence Shih-Hsin Wu, Shih-Yi Huang, et al

Clinical Pharmacology: Advances and Applications 2010, 2:105-110

Published Date: 22 June 2010

A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy

Joe D Strain, Debra K Farver, James R Clem

Clinical Pharmacology: Advances and Applications 2010, 2:95-104

Published Date: 24 May 2010

Lanthanum carbonate is not associated with QT interval modification in hemodialysis patients

Biagio Di Iorio, Emanuele Cucciniello

Clinical Pharmacology: Advances and Applications 2010, 2:89-93

Published Date: 1 June 2010

Effect of rosiglitazone and ramipril on macrovasculopathy in patients with type 2 diabetes: needs longer  treatment and/or higher doses?

Sayeeda Rahman, Aziz Al-Shafi Ismail, Shaiful Bhari Ismail, et al

Clinical Pharmacology: Advances and Applications 2010, 2:83-87

Published Date: 20 April 2010

Cosyntropin as a diagnostic agent in the screening of patients for adrenocortical insufficiency

David D Hamilton, Bryan A Cotton

Clinical Pharmacology: Advances and Applications 2010, 2:77-82

Published Date: 27 April 2010

Induction chemotherapy before autologous stem cell transplantation for symptomatic plasma cell myeloma – does it matter?

Henry C Fung, Sunita Nathan, John J Maciejewski

Clinical Pharmacology: Advances and Applications 2010, 2:71-75

Published Date: 14 April 2010

Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician

Guy Hans, Dominique Robert, Johanna Verhulst, et al

Clinical Pharmacology: Advances and Applications 2010, 2:65-70

Published Date: 30 March 2010

NMDA receptors are expressed by small-cell lung cancer and are potential targets for effective treatment

William G North, Guohong Gao, Amy Jensen, et al

Clinical Pharmacology: Advances and Applications 2010, 2:31-40

Published Date: 1 April 2010

Pharmacologic agents for smoking cessation: A clinical review

Dilip R Patel, Cynthia Feucht, Lesley Reid, et al

Clinical Pharmacology: Advances and Applications 2010, 2:17-29

Published Date: 7 April 2010

Nanoparticle-labeled stem cells: a novel therapeutic vehicle

Abir O El-Sadik, Afaf El-Ansary, Sherif M Sabry

Clinical Pharmacology: Advances and Applications 2010, 2:9-16

Published Date: 16 March 2010

The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein–Barr virus disease

Heather E Vezina, Richard C Brundage, Thomas E Nevins, et al

Clinical Pharmacology: Advances and Applications 2010, 2:1-7

Published Date: 22 December 2009